Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer
Clinical trial NCT01400438 · COMPLETED
Trial details
- NCT number
- NCT01400438
- Sponsor
- Centre Francois Baclesse
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2015-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.